Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Free Cash Flow of -$3.8 million for Q4 2025, down 119.57% on a QoQ basis from -$1.7 million in Q3 2025, and down 3754.43% year-over-year from $105067.8 in Q4 2024.
Apimeds Pharmaceuticals US (APUS) Free Cash Flow (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Free Cash Flow history runs 2 years deep, the most recent figure standing at -$3.8 million for Q4 2025.
- Quarterly Free Cash Flow fell 3754.43% year-over-year to -$3.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.0 million (down 1122.83% YoY) and the FY2025 annual result came in at -$9.0 million, down 1124.65% from the prior year.
- Free Cash Flow was -$3.8 million for Q4 2025 at Apimeds Pharmaceuticals US, down from -$1.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$20313.0 in Q1 2025 and bottomed at -$3.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 8.17 Mn | 8.17 Mn | - | -3.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.84 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -20,313.00 |
| Mar 31, 2025 | -20,313.00 |
| Dec 31, 2024 | -99,616.00 |
| Dec 31, 2024 | -99,616.00 |
| Sep 30, 2024 | -186,755.00 |
| Sep 30, 2024 | -186,755.00 |
| Jun 30, 2024 | -184,055.00 |
| Jun 30, 2024 | -184,055.00 |
| Mar 31, 2024 | -263,100.00 |
| Mar 31, 2024 | -263,100.00 |